Northwest Biotherapeutics Inc (NWBO)
0.4843
0.00 (0.00%)
USD |
OTCM |
Apr 23, 09:43
Northwest Biotherapeutics Debt to Equity Ratio: -0.6202 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.6202 |
| September 30, 2023 | -0.5058 |
| June 30, 2023 | -0.4261 |
| March 31, 2023 | -0.4756 |
| December 31, 2022 | -0.1681 |
| September 30, 2022 | -0.2399 |
| June 30, 2022 | -0.2885 |
| March 31, 2022 | -0.2346 |
| December 31, 2021 | -0.2613 |
| September 30, 2021 | -0.0677 |
| June 30, 2021 | -0.0573 |
| March 31, 2021 | -0.054 |
| December 31, 2020 | -0.0407 |
| September 30, 2020 | -0.0888 |
| June 30, 2020 | -0.1974 |
| March 31, 2020 | -0.352 |
| December 31, 2019 | -0.2824 |
| September 30, 2019 | -0.2504 |
| June 30, 2019 | -0.3048 |
| March 31, 2019 | -0.3085 |
| December 31, 2018 | -0.3562 |
| September 30, 2018 | -0.6762 |
| June 30, 2018 | -0.5141 |
| March 31, 2018 | -0.5034 |
| December 31, 2017 | -0.6646 |
| Date | Value |
|---|---|
| September 30, 2017 | -0.6304 |
| June 30, 2017 | -0.9087 |
| March 31, 2017 | -0.9079 |
| December 31, 2016 | -1.197 |
| September 30, 2016 | -4.103 |
| June 30, 2016 | -1.126 |
| March 31, 2016 | -3.548 |
| December 31, 2015 | -4.679 |
| September 30, 2015 | -0.3771 |
| June 30, 2015 | -0.3077 |
| March 31, 2015 | -0.4267 |
| December 31, 2014 | -0.6193 |
| September 30, 2014 | -0.541 |
| June 30, 2014 | -0.0392 |
| March 31, 2014 | -0.0377 |
| December 31, 2013 | -0.1245 |
| September 30, 2013 | -0.0638 |
| June 30, 2013 | -0.0835 |
| March 31, 2013 | -0.1218 |
| December 31, 2012 | -0.2409 |
| September 30, 2012 | -0.5814 |
| June 30, 2012 | -0.6619 |
| March 31, 2012 | -0.6612 |
| December 31, 2011 | -0.2925 |
| September 30, 2011 | -0.2655 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.6202
Minimum
Dec 2023
-0.0407
Maximum
Dec 2020
-0.2587
Average
-0.2504
Median
Sep 2019
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 27.86M |
| Total Liabilities (Quarterly) | 93.64M |
| Shareholders Equity (Quarterly) | -65.77M |
| Current Ratio | 0.0913 |
| Net Debt Paydown Yield | -0.36% |